Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

NCT00125463 is registered in ClinicalTrials.gov with The Japanese Society of Hypertension as lead sponsor.

NCT NCT00125463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00125463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
Lead sponsor
The Japanese Society of Hypertension
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2001
Completion date
December 31, 2005
Enrollment
3,200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, hypertension